This trial was meant to be a phase 1/2, with UTI patients treated in H2 2023.
Instead, as seems to be the trend with Recce, the trial took way longer and ended up only completing the phase 1.
Have a look at the AGM presentation from November. Even then they were claiming to aim to start a phase 3 UTI trial in 2024!
Many of us knew it was ridiculous at the time. I don't know how management thought that giving such a timeline was appropriate.
CR presentation doesn't include sepsis as a target indication anymore, surprise surprise. Yet the company has yet to actually front up honestly about the terrible plasma pharmacokinetics.
They said some of the funds are for new pre-clinical programs. I wonder if they're trying to find a formulation with a longer plasma half-life.
Anyway, bring on the loooooong overdue phase 2 UTI trial!
- Forums
- ASX - By Stock
- Ann: Phase I/II UTI/Urosepsis Rapid Infusion Trial Complete
This trial was meant to be a phase 1/2, with UTI patients...
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RCE (ASX) to my watchlist
(20min delay)
|
|||||
Last
46.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $102.0M |
Open | High | Low | Value | Volume |
46.0¢ | 46.5¢ | 46.0¢ | $19.60K | 42.56K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 41004 | 46.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
46.5¢ | 38272 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4993 | 0.460 |
6 | 185159 | 0.455 |
12 | 216338 | 0.450 |
2 | 110000 | 0.445 |
5 | 121417 | 0.440 |
Price($) | Vol. | No. |
---|---|---|
0.465 | 38272 | 2 |
0.470 | 43385 | 4 |
0.475 | 32507 | 2 |
0.480 | 16600 | 1 |
0.485 | 82243 | 1 |
Last trade - 15.56pm 26/07/2024 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |